The Beauty Health Company Statistics
Total Valuation
SKIN has a market cap or net worth of $199.67 million. The enterprise value is $417.74 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, after market close.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SKIN has 124.02 million shares outstanding. The number of shares has decreased by -8.23% in one year.
| Shares Outstanding | 124.02M |
| Shares Change (YoY) | -8.23% |
| Shares Change (QoQ) | -1.76% |
| Owned by Insiders (%) | 8.15% |
| Owned by Institutions (%) | 66.19% |
| Float | 80.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.56 |
| Forward PS | 0.50 |
| PB Ratio | 2.89 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.49, with a Debt / Equity ratio of 8.20.
| Current Ratio | 6.49 |
| Quick Ratio | 5.31 |
| Debt / Equity | 8.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.36 |
Financial Efficiency
Return on equity (ROE) is -72.46% and return on invested capital (ROIC) is -11.25%.
| Return on Equity (ROE) | -72.46% |
| Return on Assets (ROA) | -10.15% |
| Return on Capital (ROIC) | -11.25% |
| Revenue Per Employee | $415,699 |
| Profits Per Employee | -$95,003 |
| Employee Count | 881 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.65 |
Taxes
In the past 12 months, SKIN has paid $3.07 million in taxes.
| Income Tax | 3.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.24% in the last 52 weeks. The beta is 0.91, so SKIN's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | -63.24% |
| 50-Day Moving Average | 1.58 |
| 200-Day Moving Average | 2.43 |
| Relative Strength Index (RSI) | 49.23 |
| Average Volume (20 Days) | 721,998 |
Short Selling Information
The latest short interest is 9.69 million, so 7.81% of the outstanding shares have been sold short.
| Short Interest | 9.69M |
| Short Previous Month | 9.78M |
| Short % of Shares Out | 7.81% |
| Short % of Float | 12.03% |
| Short Ratio (days to cover) | 10.30 |
Income Statement
In the last 12 months, SKIN had revenue of $366.23 million and -$83.70 million in losses. Loss per share was -$0.87.
| Revenue | 366.23M |
| Gross Profit | 122.43M |
| Operating Income | -139.56M |
| Pretax Income | -80.63M |
| Net Income | -83.70M |
| EBITDA | -104.04M |
| EBIT | -139.56M |
| Loss Per Share | -$0.87 |
Full Income StatementBalance Sheet
The company has $349.54 million in cash and $567.61 million in debt, giving a net cash position of -$218.06 million or -$1.76 per share.
| Cash & Cash Equivalents | 349.54M |
| Total Debt | 567.61M |
| Net Cash | -218.06M |
| Net Cash Per Share | -$1.76 |
| Equity (Book Value) | 69.19M |
| Book Value Per Share | 0.56 |
| Working Capital | 414.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.14 million and capital expenditures -$2.42 million, giving a free cash flow of -$282,000.
| Operating Cash Flow | 2.14M |
| Capital Expenditures | -2.42M |
| Free Cash Flow | -282,000 |
| FCF Per Share | -$0.00 |
Full Cash Flow StatementMargins
Gross margin is 33.43%, with operating and profit margins of -38.11% and -22.85%.
| Gross Margin | 33.43% |
| Operating Margin | -38.11% |
| Pretax Margin | -22.02% |
| Profit Margin | -22.85% |
| EBITDA Margin | -28.41% |
| EBIT Margin | -38.11% |
| FCF Margin | -1.85% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.23% |
| Shareholder Yield | 8.23% |
| Earnings Yield | -41.92% |
| FCF Yield | -0.14% |
Analyst Forecast
The average price target for SKIN is $2.29, which is 42.24% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.29 |
| Price Target Difference | 42.24% |
| Analyst Consensus | Hold |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 6.79% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SKIN has an Altman Z-Score of 0.14 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.14 |
| Piotroski F-Score | 4 |